Clinical Predictive Factors associated with First Line EGFR-TKI Efficacy 
in Advanced NSCLC Patients with EGFR Mutations

Clinical Predictive Factors associated with First Line EGFR-TKI Efficacy 
in Advanced NSCLC Patients with EGFR Mutations

Background and objective Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have demonstrated some dramatic efficacy in advanced non-small-cell lung cancer (NSCLC) patients with activating EGFR mutation. However, progression-free survivals (PFS) among those patients who were tre...

Full description

Bibliographic Details
Main Authors: Minjiang CHEN, Yan XU, Jing ZHAO, Wei ZHONG, Mengzhao WANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2019-02-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Predictive factor
Epidermal growth factor receptor tyrosine kinase inhibitors
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2019.02.04

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2019.02.04

Similar Items